Breast Biopsy Devices Market

The global sales of breast biopsy devices are estimated to be worth USD 2.47 billion in 2025 and anticipated to reach a value of USD 4.21 billion by 2035. Sales are projected to rise at a CAGR of 5.5% over the forecast period between 2025 and 2035. The revenue generated by breast biopsy devices in 2024 was USD 2.34 billion. Suspicious solid mass is expected to hold a 29.7% share in 2025, which is attributed to due to the widespread occurrence of fibroadenomas. Hospitals will dominate the end user segment with a 45% market share, owing to the availability of advanced diagnostic infrastructure and the high volume of breast biopsy procedures performed in hospital settings.